176 related articles for article (PubMed ID: 30154115)
1. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
[No Abstract] [Full Text] [Related]
2. Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.
Thomas KR; Allenspach EJ; Camp ND; Wray-Dutra MN; Khim S; Zielinska-Kwiatkowska A; Timms AE; Loftus JP; Liggitt HD; Georgopoulos K; Tasian SK; James RG; Rawlings DJ
Leukemia; 2022 Jan; 36(1):42-57. PubMed ID: 34193976
[TBL] [Abstract][Full Text] [Related]
3. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
Castro FV; McGinn OJ; Krishnan S; Marinov G; Li J; Rutkowski AJ; Elkord E; Burt DJ; Holland M; Vaghjiani R; Gallego A; Saha V; Stern PL
Leukemia; 2012 Jul; 26(7):1487-98. PubMed ID: 22266911
[TBL] [Abstract][Full Text] [Related]
4. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
5. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
[TBL] [Abstract][Full Text] [Related]
6. Relapse of acute lymphoblastic leukemia in the inferior rectus muscle of the eye.
Hinkle AS; Dinndorf PA; Bulas DI; Kapur S
Cancer; 1994 Mar; 73(6):1757-60. PubMed ID: 8156504
[TBL] [Abstract][Full Text] [Related]
7. Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous system.
Rajakumar SA; Grandal I; Minden MD; Hitzler JK; Guidos CJ; Danska JS
Cell Rep Med; 2021 Dec; 2(12):100470. PubMed ID: 35028611
[TBL] [Abstract][Full Text] [Related]
8. The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
Williams MT; Yousafzai YM; Elder A; Rehe K; Bomken S; Frishman-Levy L; Tavor S; Sinclair P; Dormon K; Masic D; Perry T; Weston VJ; Kearns P; Blair H; Russell LJ; Heidenreich O; Irving JA; Izraeli S; Vormoor J; Graham GJ; Halsey C
Blood; 2016 Apr; 127(16):1998-2006. PubMed ID: 26869395
[TBL] [Abstract][Full Text] [Related]
9. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
[TBL] [Abstract][Full Text] [Related]
11. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
Velázquez-Avila M; Balandrán JC; Ramírez-Ramírez D; Velázquez-Avila M; Sandoval A; Felipe-López A; Nava P; Alvarado-Moreno JA; Dozal D; Prieto-Chávez JL; Schaks M; Rottner K; Dorantes-Acosta E; López-Martínez B; Schnoor M; Pelayo R
Leukemia; 2019 Jun; 33(6):1337-1348. PubMed ID: 30573781
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.
Almeida ARM; Neto JL; Cachucho A; Euzébio M; Meng X; Kim R; Fernandes MB; Raposo B; Oliveira ML; Ribeiro D; Fragoso R; Zenatti PP; Soares T; de Matos MR; Corrêa JR; Duque M; Roberts KG; Gu Z; Qu C; Pereira C; Pyne S; Pyne NJ; Barreto VM; Bernard-Pierrot I; Clappier E; Mullighan CG; Grosso AR; Yunes JA; Barata JT
Nat Commun; 2021 Dec; 12(1):7268. PubMed ID: 34907175
[TBL] [Abstract][Full Text] [Related]
13. An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.
Geron I; Savino AM; Fishman H; Tal N; Brown J; Turati VA; James C; Sarno J; Hameiri-Grossman M; Lee YN; Rein A; Maniriho H; Birger Y; Zemlyansky A; Muler I; Davis KL; Marcu-Malina V; Mattson N; Parnas O; Wagener R; Fischer U; Barata JT; Jamieson CHM; Müschen M; Chen CW; Borkhardt A; Kirsch IR; Nagler A; Enver T; Izraeli S
Nat Commun; 2022 Feb; 13(1):659. PubMed ID: 35115489
[TBL] [Abstract][Full Text] [Related]
14. Unusual sites of relapse in pre-B acute lymphoblastic leukemia.
Jain R; Trehan A; Singh R; Srinivasan R; Dogra M; Bansal D; Marwaha RK
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e506-8. PubMed ID: 25171446
[TBL] [Abstract][Full Text] [Related]
15. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
van der Velden VH; de Launaij D; de Vries JF; de Haas V; Sonneveld E; Voerman JS; de Bie M; Revesz T; Avigad S; Yeoh AE; Swagemakers SM; Eckert C; Pieters R; van Dongen JJ
Br J Haematol; 2016 Mar; 172(5):769-81. PubMed ID: 26898195
[TBL] [Abstract][Full Text] [Related]
16. CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.
Mejstríková E; Hrusak O; Borowitz MJ; Whitlock JA; Brethon B; Trippett TM; Zugmaier G; Gore L; von Stackelberg A; Locatelli F
Blood Cancer J; 2017 Dec; 7(12):659. PubMed ID: 29259173
[No Abstract] [Full Text] [Related]
17. Relapse of acute lymphoblastic leukemia in the jaw.
Bakathir AA; Al-Hamdani AS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):e14-6. PubMed ID: 19426901
[TBL] [Abstract][Full Text] [Related]
18. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia.
Kinjyo I; Matlawska-Wasowska K; Chen X; Monks NR; Burke P; Winter SS; Wilson BS
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449314
[TBL] [Abstract][Full Text] [Related]
20. CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.
Lenk L; Carlet M; Vogiatzi F; Spory L; Winterberg D; Cousins A; Vossen-Gajcy M; Ibruli O; Vokuhl C; Cario G; El Ayoubi O; Kramer L; Ritgen M; Brüggemann M; Häsler R; Schrappe M; Fuhrmann S; Halsey C; Jeremias I; Hobeika E; Jumaa H; Alsadeq A; Schewe DM
Commun Biol; 2021 Jan; 4(1):73. PubMed ID: 33452446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
